News & Perspective

Oct 25, 2019

Oct 25, 2019

ASP Scan (Weekly) for Oct 25, 2019

New guidelines for dental antibiotics
Antibiotics R&D roadmap
Colistin-resistant K pneumoniae in India
Transmissibility of MDR-TB
High-intensity stewardship
Urgent care antibiotic prescribing
Stewardship in low-income nations
G20 health leaders' AMR commitment
Veterinary stewardship progress
Stewardship in ambulatory settings
Rising resistance in H pylori
Costs of antibiotic development incentive
Rapid diagnostic test evaluation
Antibiotic Rx and chronic disease

Aug 23, 2019

Aug 23, 2019

ASP Scan (Weekly) for Aug 23, 2019

Better nursing home stewardship
New antimicrobial resistance coalition
Single-patient hospital rooms
Antimicrobial resistance grants
Resistant malaria in Africa
Improper antibiotic Rx in UK
Combo drug for urinary infections
Parenteral antibiotics in neonates
Funds for superbug vaccine
Carbapenem susceptibility tests
New Australian AMR hub

Jan 18, 2019

Jan 18, 2019

ASP Scan (Weekly) for Jan 18, 2019

New CARB-X funding
VRE in Swiss hospitals
Antibiotic overprescribing in tots
Fast track for new C diff drug
Stewardship in pediatric surgery
MRSA decline in Germany
Antibiotic resistance on pig farms
Resistance genes in Bolivian river
Stewardship in English hospitals
Whiff of C diff in pets
Fecal microbiota transplant trial

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Apr 17, 2003

Apr 17, 2003

Only 35 'probable' SARS cases in US, says CDC

(CIDRAP News) – Federal health officials said today that only 35 people in the United States have "probable" cases of severe acute respiratory syndrome (SARS), a small fraction of the 208 suspected cases under investigation.

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»